Literature DB >> 19968917

Proinflammatory cytokines and osteoporosis.

Robert R McLean1.   

Abstract

Experimental studies indicate that the proinflammatory cytokines interleukin-1, interleukin-6, and tumor necrosis factor-alpha are important regulators of bone resorption and may play an important role in age- and estrogen deficiency-related bone loss. Although the observation of accelerated bone loss in patients with inflammatory disorders supports this mechanism, the role of cytokines in the etiology of osteoporosis has yet to be determined. Elucidation of this potential relationship could not only provide clinicians with an additional tool to identify patients at risk for osteoporosis, but may also inform the development of cytokine-blocking therapies as potential interventions to curb bone loss. Although some epidemiologic studies suggest increases in proinflammatory cytokines are associated with decreased bone mass and greater fracture risk, the totality of evidence is limited and provides no clear indication of which cytokines may be most important for bone health. Additional studies are required to establish if inflammation is an important risk factor for osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19968917     DOI: 10.1007/s11914-009-0023-2

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  46 in total

1.  Cytokines and bone loss in a 5-year longitudinal study--hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study.

Authors:  B Abrahamsen; V Bonnevie-Nielsen; E N Ebbesen; J Gram; H Beck-Nielsen
Journal:  J Bone Miner Res       Date:  2000-08       Impact factor: 6.741

2.  High-sensitivity C-reactive protein and fracture risk in elderly women.

Authors:  Julie A Pasco; Mark A Kotowicz; Margaret J Henry; Geoffrey C Nicholson; Heather J Spilsbury; Jeffrey D Box; Hans G Schneider
Journal:  JAMA       Date:  2006-09-20       Impact factor: 56.272

Review 3.  Cytokines, bone remodeling, and estrogen deficiency: a 1998 update.

Authors:  R L Jilka
Journal:  Bone       Date:  1998-08       Impact factor: 4.398

4.  Increase in cytokine production (IL-1 beta, IL-6, TNF-alpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis.

Authors:  S X Zheng; Y Vrindts; M Lopez; D De Groote; P F Zangerle; J Collette; N Franchimont; V Geenen; A Albert; J Y Reginster
Journal:  Maturitas       Date:  1997-01       Impact factor: 4.342

Review 5.  The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

Authors:  L C Hofbauer; S Khosla; C R Dunstan; D L Lacey; W J Boyle; B L Riggs
Journal:  J Bone Miner Res       Date:  2000-01       Impact factor: 6.741

6.  High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study.

Authors:  Georg Schett; Stefan Kiechl; Siegfried Weger; Angelo Pederiva; Agnes Mayr; Manuele Petrangeli; Friedrich Oberhollenzer; Rolando Lorenzini; Kurt Redlich; Roland Axmann; Jochen Zwerina; Johann Willeit
Journal:  Arch Intern Med       Date:  2006 Dec 11-25

7.  Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause.

Authors:  C Scheidt-Nave; H Bismar; G Leidig-Bruckner; H Woitge; M J Seibel; R Ziegler; J Pfeilschifter
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

8.  Cytokines and T-lymphocyte subsets in healthy post-menopausal women: estrogen retards bone loss without affecting the release of IL-1 or IL-1ra.

Authors:  B Abrahamsen; K Bendtzen; H Beck-Nielsen
Journal:  Bone       Date:  1997-03       Impact factor: 4.398

Review 9.  Inflammatory mediators as essential elements in bone remodeling.

Authors:  S R Goldring
Journal:  Calcif Tissue Int       Date:  2003-08       Impact factor: 4.333

10.  There is no difference in spontaneous and 17 beta-estradiol-induced interleukin-1 beta release by peripheral blood mononuclear cells from nonosteoporotic women with different rates of early postmenopausal bone loss.

Authors:  A K Høgåsen; L Nordsletten; A O Aasen; J A Falch
Journal:  J Clin Endocrinol Metab       Date:  1995-08       Impact factor: 5.958

View more
  76 in total

1.  Effects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in rheumatoid arthritis: a population-based cohort study.

Authors:  Seo Young Kim; Sebastian Schneeweiss; Jun Liu; Daniel H Solomon
Journal:  J Bone Miner Res       Date:  2012-04       Impact factor: 6.741

2.  Risk of fragility fracture among patients with sarcoidosis: a population-based study 1976-2013.

Authors:  P Ungprasert; C S Crowson; E L Matteson
Journal:  Osteoporos Int       Date:  2017-02-16       Impact factor: 4.507

3.  Effects of Oxidative Stress and Testosterone on Pro-Inflammatory Signaling in a Female Rat Dopaminergic Neuronal Cell Line.

Authors:  Shaletha Holmes; Meharvan Singh; Chang Su; Rebecca L Cunningham
Journal:  Endocrinology       Date:  2016-05-11       Impact factor: 4.736

Review 4.  Rodent models of aging bone: an update.

Authors:  Farhan A Syed; Terry Melim
Journal:  Curr Osteoporos Rep       Date:  2011-12       Impact factor: 5.096

5.  Naringin rescued the TNF-α-induced inhibition of osteogenesis of bone marrow-derived mesenchymal stem cells by depressing the activation of NF-кB signaling pathway.

Authors:  Xvhai Cao; Weilong Lin; Chengwei Liang; Dong Zhang; Fengjian Yang; Yan Zhang; Xuelin Zhang; Jianyong Feng; Cong Chen
Journal:  Immunol Res       Date:  2015-07       Impact factor: 2.829

Review 6.  Combating osteoporosis and obesity with exercise: leveraging cell mechanosensitivity.

Authors:  Gabriel M Pagnotti; Maya Styner; Gunes Uzer; Vihitaben S Patel; Laura E Wright; Kirsten K Ness; Theresa A Guise; Janet Rubin; Clinton T Rubin
Journal:  Nat Rev Endocrinol       Date:  2019-06       Impact factor: 43.330

7.  Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking?

Authors:  Bram van den Borst; Annemarie Koster; Binbing Yu; Harry R Gosker; Bernd Meibohm; Douglas C Bauer; Stephen B Kritchevsky; Yongmei Liu; Anne B Newman; Tamara B Harris; Annemie M W J Schols
Journal:  Thorax       Date:  2011-07-01       Impact factor: 9.139

Review 8.  The epidemiology of osteoporosis.

Authors:  Michael A Clynes; Nicholas C Harvey; Elizabeth M Curtis; Nicholas R Fuggle; Elaine M Dennison; Cyrus Cooper
Journal:  Br Med Bull       Date:  2020-05-15       Impact factor: 4.291

Review 9.  Osteoporosis and Periodontitis.

Authors:  Chin-Wei Jeff Wang; Laurie K McCauley
Journal:  Curr Osteoporos Rep       Date:  2016-12       Impact factor: 5.096

Review 10.  [Mechanobiology and bone metabolism: Clinical relevance for fracture treatment].

Authors:  M Haffner-Luntzer; A Liedert; A Ignatius
Journal:  Unfallchirurg       Date:  2015-12       Impact factor: 1.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.